相关实验视频

Updated: Jan 14, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

聚胺-尼罗河蓝相互作用的综合实验和计算调查:结合机制,抗氧化活性和PLS建模

C Manivannan¹, Sambath Baskaran², Thayalaraj Christopher Jeyakumar³

¹Division of Chemistry, School of Sciences, SRM Institute of Science and Technology, Tiruchirappalli, Tamilnadu, 621105, India. cmanivannan89@gmail.com.

Journal of fluorescence

|October 20, 2025

概括

这项研究揭示了使用光和计算方法的黄类结构如何影响抗氧化剂活性. 与尼罗河蓝色染料的黄类相互作用与抗氧化能力相关,有助于开发新的生物传感器和治疗工具.

科学领域:

生物化学生化学
摄影化学的使用.
分析化学分析化学

背景情况:

黄酸是具有多种生物活性的天然抗氧化剂.
光谱学是研究分子相互作用的宝贵工具.

研究的目的:

为了研究各种类黄和光染料尼罗河蓝 (NB) 之间的光诱导相互作用.
为了将黄胺结构与其火效率和抗氧化活性相关联.

主要方法:

结合计算和实验光技术 (稳定状态和时间解析).
紫外线可见吸收光谱学.
脱氧核糖分解试验. 脱氧核糖分解试验.
部分最小平方 (PLS) 回归分析.

主要成果:

黄类药物灭尼罗河蓝色光,表明基态复合物形成.
火效率受到溶剂极性,pH值和黄化合物结构的影响.
确定了一种静态火机制,速度常数与BDE和基组位置相关.
抗氧化剂活性趋势与光灭效率保持一致.
PLS回归揭示了电子特征和火行为之间的强烈相关性.

结论:

黄酸的结构特征决定了它们与尼罗河蓝的相互作用及其抗氧化能力.
这项研究为开发新型抗氧化剂查试验,光引导疗法和基于黄类生物传感器提供了基础.

关键词:

抗氧化剂是一种抗氧化剂.黄类化合物黄类化合物光灭的光灭方式尼罗河蓝色尼罗河蓝色部分线性正方形分析

更多相关视频

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Protein-Drug Binding: Mechanism and Kinetics

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...